Clinical Operations, • 9/22/25 Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter Previous Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources Next Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development You Might Also Like Aligning Trials with Patient-Lived Experiences Solutions for Trial Design Challenges in Rare Disease Trials What Matters to Payers: Conversations You Should Start During Phase 2 How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Leveraging Patient Advocacy To Scale Rare Disease Trials
Clinical Operations, • 9/22/25 Purpose-Driven Metrics: Running Gene Therapy Trials with KPIs That Matter Previous Beyond the Feasibility Survey: Strategic Site Selection to Accelerate Trials and Optimize Resources Next Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development You Might Also Like Aligning Trials with Patient-Lived Experiences Solutions for Trial Design Challenges in Rare Disease Trials What Matters to Payers: Conversations You Should Start During Phase 2 How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Leveraging Patient Advocacy To Scale Rare Disease Trials
